SC
CL icon

Savant Capital’s Colgate-Palmolive CL Stock Holding History

Savant Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.99M Buy
35,040
+6,224
+22% +$555K 0.01% 355
2025
Q4 		$2.28M Buy
28,816
+1,419
+5% +$111K 0.01% 384
2025
Q3 		$2.19M Sell
27,397
-348
-1% -$29.7K 0.01% 380
2025
Q2 		$2.52M Buy
27,745
+1,914
+7% +$175K 0.02% 327
2025
Q1 		$2.42M Sell
25,831
-17,025
-40% -$1.52M 0.02% 304
2024
Q4 		$3.9M Buy
42,856
+1,631
+4% +$156K 0.03% 279
2024
Q3 		$4.28M Buy
41,225
+2,638
+7% +$269K 0.04% 243
2024
Q2 		$3.74M Buy
38,587
+4,085
+12% +$377K 0.04% 237
2024
Q1 		$3.11M Buy
34,502
+18,345
+114% +$1.55M 0.04% 255
2023
Q4 		$1.29M Buy
16,157
+31
+0.2% +$2.33K 0.02% 364
2023
Q3 		$1.15M Buy
16,126
+100
+0.6% +$7.48K 0.02% 360
2023
Q2 		$1.23M Buy
16,026
+953
+6% +$73.8K 0.02% 336
2023
Q1 		$1.13M Buy
15,073
+7,598
+102% +$565K 0.02% 307
2022
Q4 		$589K Sell
7,475
-276
-4% -$20.7K 0.01% 337
2022
Q3 		$545K Sell
7,751
-297
-4% -$23.3K 0.02% 331
2022
Q2 		$645K Buy
8,048
+47
+0.6% +$3.67K 0.02% 307
2022
Q1 		$606K Buy
8,001
+225
+3% +$17.8K 0.02% 321
2021
Q4 		$664K Buy
7,776
+295
+4% +$23K 0.02% 307
2021
Q3 		$565K Sell
7,481
-1,379
-16% -$110K 0.02% 303
2021
Q2 		$721K Sell
8,860
-144
-2% -$11.8K 0.03% 244
2021
Q1 		$710K Buy
9,004
+30
+0.3% +$2.35K 0.04% 230
2020
Q4 		$767K Sell
8,974
-366
-4% -$30.3K 0.04% 210
2020
Q3 		$721K Sell
9,340
-937
-9% -$71.4K 0.05% 205
2020
Q2 		$753K Buy
10,277
+178
+2% +$12.6K 0.06% 193
2020
Q1 		$670K Buy
10,099
+802
+9% +$56.6K 0.06% 190
2019
Q4 		$640K Buy
9,297
+1,071
+13% +$73K 0.08% 181
2019
Q3 		$605K Sell
8,226
-106
-1% -$7.69K 0.08% 171
2019
Q2 		$597K Sell
8,332
-1,211
-13% -$86K 0.08% 169
2019
Q1 		$654K Buy
9,543
+98
+1% +$6.33K 0.12% 129
2018
Q4 		$562K Sell
9,445
-205
-2% -$12.8K 0.12% 133
2018
Q3 		$646K Sell
9,650
-285
-3% -$19K 0.12% 133
2018
Q2 		$644K Sell
9,935
-239
-2% -$15.6K 0.14% 123
2018
Q1 		$729K Sell
10,174
-135
-1% -$9.71K 0.15% 111
2017
Q4 		$778K Sell
10,309
-299
-3% -$21.8K 0.16% 107
2017
Q3 		$773K Sell
10,608
-117
-1% -$8.43K 0.17% 92
2017
Q2 		$795K Buy
10,725
+199
+2% +$14.8K 0.19% 86
2017
Q1 		$770K Buy
10,526
+30
+0.3% +$2.1K 0.19% 84
2016
Q4 		$687K Buy
10,496
+12
+0.1% +$823 0.18% 91
2016
Q3 		$777K Buy
10,484
+2,146
+26% +$159K 0.21% 78
2016
Q2 		$610K Buy
8,338
+1,770
+27% +$126K 0.17% 99
2016
Q1 		$464K Buy
6,568
+300
+5% +$20K 0.14% 119
2015
Q4 		$418K Sell
6,268
-222
-3% -$14.8K 0.13% 126
2015
Q3 		$412K Sell
6,490
-40
-0.6% -$2.61K 0.15% 115
2015
Q2 		$427K Buy
6,530
+40
+0.6% +$2.71K 0.14% 123
2015
Q1 		$450K Sell
6,490
-10
-0.2% -$691 0.16% 111
2014
Q4 		$450K Sell
6,500
-10
-0.2% -$675 0.17% 103
2014
Q3 		$425K Sell
6,510
-10
-0.2% -$660 0.18% 96
2014
Q2 		$445K Hold
6,520
– – 0.19% 90
2014
Q1 		$423K Buy
6,520
+255
+4% +$16.1K 0.2% 91
2013
Q4 		$409K Sell
6,265
-39
-0.6% -$2.5K 0.2% 83
2013
Q3 		$374K Buy
6,304
+270
+4% +$16K 0.2% 81
2013
Q2 		$346K Buy
+6,034
New +$358K 0.2% 86

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Savant Capital's CL Position: Q1 2026 in Review

Savant Capital increased its Colgate-Palmolive (CL) stake by 22% in Q1 2026, buying an estimated $555K and bringing the position to 35,040 shares worth $2.99M. The position accounts for 0.01% of the portfolio, ranked #355.

Savant Capital first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.28M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Savant Capital held 35,040 shares of Colgate-Palmolive worth $2.99M as of Q1 2026.
  • Savant Capital bought 6,224 Colgate-Palmolive shares in Q1 2026, an estimated $555K.
  • Colgate-Palmolive made up 0.01% of Savant Capital's portfolio in Q1 2026, its #355 holding.
  • Savant Capital first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Savant Capital's Colgate-Palmolive position peaked at $4.28M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Savant Capital's 13F filing for Q1 2026, filed 4 May 2026.